- Home
- JYNT vs ME Comparison
JYNT vs ME Comparison
Compare JYNT & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JYNT
- ME
- Stock Information
- Founded
- JYNT 2010
- ME 2006
- Country
- JYNT United States
- ME United States
- Employees
- JYNT N/A
- ME N/A
- Industry
- JYNT Multi-Sector Companies
- ME Precision Instruments
- Sector
- JYNT Miscellaneous
- ME Health Care
- Exchange
- JYNT Nasdaq
- ME Nasdaq
- Market Cap
- JYNT 163.0M
- ME 168.9M
- IPO Year
- JYNT 2014
- ME N/A
- Fundamental
- Price
- JYNT $11.70
- ME $0.34
- Analyst Decision
- JYNT Strong Buy
- ME Hold
- Analyst Count
- JYNT 2
- ME 1
- Target Price
- JYNT $18.00
- ME $0.47
- AVG Volume (30 Days)
- JYNT 58.2K
- ME 2.4M
- Earning Date
- JYNT 11-07-2024
- ME 11-06-2024
- Dividend Yield
- JYNT N/A
- ME N/A
- EPS Growth
- JYNT N/A
- ME N/A
- EPS
- JYNT N/A
- ME N/A
- Revenue
- JYNT $120,071,078.00
- ME $199,188,000.00
- Revenue This Year
- JYNT $0.70
- ME $0.05
- Revenue Next Year
- JYNT N/A
- ME $17.98
- P/E Ratio
- JYNT N/A
- ME N/A
- Revenue Growth
- JYNT 7.46
- ME N/A
- 52 Week Low
- JYNT $7.31
- ME $0.29
- 52 Week High
- JYNT $17.82
- ME $1.12
- Technical
- Relative Strength Index (RSI)
- JYNT 51.57
- ME 51.25
- Support Level
- JYNT $10.80
- ME $0.29
- Resistance Level
- JYNT $12.02
- ME $0.32
- Average True Range (ATR)
- JYNT 0.40
- ME 0.02
- MACD
- JYNT 0.14
- ME 0.01
- Stochastic Oscillator
- JYNT 81.10
- ME 98.57
About JYNT The Joint Corp.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.